Ray Therapeutics Funding: $230M Raised, Series B (2026)
Ray Therapeutics is based in Berkeley, California. It has raised $230M in total funding. Latest round: Series B.
Ray Therapeutics funding overview
Ray Therapeutics is based in Berkeley, California. Ray Therapeutics has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Ray Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Ray Therapeutics at a glance
Total raised
$230M
Latest round
Series B
Latest round date
January 2026
Headquarters
Berkeley, California
Notable investors
Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital, Deerfield Management, MRL Ventures Fund
Frequently asked about Ray Therapeutics funding
How much has Ray Therapeutics raised?
Ray Therapeutics has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Ray Therapeutics?
Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital are named among the investors backing Ray Therapeutics.
What was the latest Ray Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2026.
Where is Ray Therapeutics based?
Ray Therapeutics is based in Berkeley, California.
When did Ray Therapeutics last raise?
The last disclosed Ray Therapeutics round closed in January 2026 at Series B.
Ray Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Berkeley below to benchmark round size and investor mix.
